Edition:
United States

PTC Therapeutics Inc (PTCT.OQ)

PTCT.OQ on NASDAQ Stock Exchange Global Select Market

39.98USD
20 Jul 2018
Change (% chg)

$3.43 (+9.38%)
Prev Close
$36.55
Open
$38.52
Day's High
$40.77
Day's Low
$38.50
Volume
638,911
Avg. Vol
395,473
52-wk High
$52.95
52-wk Low
$14.57

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 56.06 -0.463
FY 2017 Dec '17 78.03 1.143
Sep '17 41.85 -0.817
Jun '17 47.96 -0.441
Mar '17 26.55 -0.847
FY 2016 Dec '16 25.19 -0.784
Sep '16 22.99 -1.032
Jun '16 15.63 -1.145
Mar '16 18.90 -1.216
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 70.73 76.61 63.58 46.60
Quarter Ending Dec-18 5 85.98 100.12 76.40 50.00
Year Ending Dec-18 7 270.04 298.81 220.00 186.16
Year Ending Dec-19 7 355.28 391.30 277.00 247.82
Earnings (per share)
Quarter Ending Sep-18 6 -0.31 -0.18 -0.49 -0.70
Quarter Ending Dec-18 6 -0.08 0.36 -0.35 -0.67
Year Ending Dec-18 7 -1.30 -0.29 -2.81 -2.38
Year Ending Dec-19 8 -0.02 1.03 -1.63 -1.72
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 217.69 33.34
P/E High - Last 5 Yrs. -- 284.50 47.12
P/E Low - Last 5 Yrs. -- 96.76 24.95
Beta 1.82 0.76 0.81
Price to Sales (TTM) 7.58 256.17 8.11
Price to Book (MRQ) 11.12 21.19 4.23
Price to Tangible Book (MRQ) 74.64 27.03 6.21
Price to Cash Flow (TTM) -- 128.89 22.22
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.72
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.25 -6.39
Payout Ratio(TTM) -- 84.35 47.39

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 111.18 33.43 4.76
Sales (TTM) vs TTM 1 Yr. Ago 147.80 147.14 12.32
Sales - 5 Yr. Growth Rate 41.77 30.77 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago 45.36 -79.61 48.99
EPS (TTM) vs TTM 1 Yr. Ago 84.83 -- --
EPS - 5 Yr. Growth Rate -- 46.75 7.97
Capital Spending - 5 Yr. Growth Rate 75.05 42.60 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.16 1.72 2.56
Current Ratio (MRQ) 3.33 6.63 3.63
LT Debt to Equity (MRQ) 97.72 24.46 13.08
Total Debt to Equity (MRQ) 97.72 28.66 17.18
Interest Coverage (TTM) -14.05 -154.53 35.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 96.51 55.90 55.23
Gross Margin - 5 Yr. Avg. -- 53.43 53.18
EBITD Margin (TTM) -14.11 -- --
EBITD - 5 Yr. Avg -128.36 -182.15 15.61
Operating Margin (TTM) -24.42 -964.42 -0.70
Operating Margin - 5 Yr. Avg. -136.01 -195.77 10.75
Pre-Tax Margin (TTM) -30.29 -858.38 1.18
Pre-Tax Margin - 5 Yr. Avg. -144.24 -200.51 10.87
Net Profit Margin (TTM) -10.32 -849.10 -2.12
Net Profit Margin - 5 Yr. Avg. -131.29 -198.30 7.23
Effective Tax Rate (TTM) -- 14.86 20.83
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 600,287 23,539,371 740,084,415
Net Income/Employee (TTM) -61,946 -1,115,845 86,307,671
Receivable Turnover (TTM) 5.76 17.88 5.95
Inventory Turnover (TTM) 1.14 2.85 3.69
Asset Turnover (TTM) 0.71 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -7.36 -2.23 10.36
Return on Assets - 5 Yr. Avg. -37.12 2.95 11.03
Return on Investment (TTM) -9.06 -3.65 13.18
Return on Investment - 5 Yr. Avg. -43.57 2.79 14.26
Return on Equity (TTM) -18.40 -5.62 15.09
Return on Equity - 5 Yr. Avg. -62.50 -4.53 15.57
  1 Year 3 Year 5 Year
Sales % 135.04 97.47 41.77
EPS (TTM) % 79.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for PTC Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.02 9.16 83 45
13 Week 52.42 45.26 90 62
26 Week 82.39 82.94 93 69
52 Week 96.56 73.52 85 85
YTD 139.69 128.72 96 86
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 85.98%
# of Holders: 213
Total Shares Held: 39,936,007
3 Mo. Net Change: -3,328,556
# New Positions: 9
# Closed Positions: 3
# Increased Positions: 15
# Reduced Positions: 13
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.